Q2 2025 Financial Results: Mixed Outcomes for Swedish Tech Firms

As of August 14, 2025, several Swedish technology and communication companies have reported their financial results for Q2 2025, revealing a mixed bag of performance in a challenging market context.

**Implantica**, focused on medical technology, faced operational losses of €4.5 million, although this marked an improvement from €5.9 million in the same quarter last year. Net revenue decreased by 22% to €0.4 million from €0.6 million, largely impacted by ongoing patient recruitment for clinical trials. The company had €56.3 million in cash reserves and CEO Peter Forsell noted significant progress in regulatory and clinical validation.

**Kebni**, specializing in antenna and sensor solutions, reported a strong Q2 with an EBITDA of 4.9 million SEK, up from 3.1 million SEK year-over-year, signaling positive growth.

In contrast, **Transtema** reported higher revenue with an EBITA of 22.1 million SEK, establishing itself as a strong performer amidst peers facing difficulties.

**Relevance Communication** reported slight revenue growth with net earnings of 9.6 million SEK and a positive operating profit before depreciation of 94,000 SEK amid a tough advertising market. CEO Fredrik Lundberg highlighted the weakness in advertising investments affecting their performance.

Finally, **CAG** faced a decline with an adjusted EBITA of 17.9 million SEK, down from 19.0 million SEK last year, with prevailing negative organic growth also noted in companies like Embracer and Yubico.

As the financial landscape shifts, these results illustrate the varied impacts of current economic conditions on these prominent Swedish tech firms.